Search Results
The impact of IDH mutations on the outcomes of patients with AML & inhibitors under investigation
The prognostic impact of IDH mutations and the role of IDH inhibitors in MDS
Clinical trials investigating treatment approaches for FLT3-mutated and IDH-mutated AML patients
The impact of IDH mutated clones in NPM1+ AML
Treatment strategies for patients with IDH1/2-mutated AML ineligible for intensive chemotherapy
Targeting IDH mutations for the treatment of AML
IDH Mutations in AML
Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical Pathways
The efficacy of olutasidenib in patients with R/R IDH-mutant AML
IDH1/2 Inhibitors for AML
IDH inhibitors for AML and MDS
The Patient is In: Introduction to IDH-mutant cancers with Matthew Vander Heiden
